NIH Foundation, Biomarkers Consortium Team on Cancer Trials | GenomeWeb

This article has been updated with comments from a press conference.

By Matt Jones

NEW YORK (GenomeWeb News) – Government and university scientists in the US and drug development companies will undertake a new personalized clinical trial model that will use genetic biomarkers from individual tumors to screen several new drugs for breast cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.